Close Menu

NEW YORK (GenomeWeb) – Diagnostics firm MeMed said today it has received a $4.1 million grant from the US Department of Defense's Congressionally Directed Medical Research Programs (CDMRP).

The company will use the funds to further develop a point-of-care platform on which it plans to offer its ImmunoXpert test for distinguishing between viral and bacterial infections.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.